About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effects of HFMH-EMS on Ocular Artery Circulation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT06861985

Effects of HFMH-EMS on Ocular Artery Circulation

Investigated the effects of high-frequency multi-band harmonic electromagnetic stimulation on ophthalmic and central retinal artery circulation.

Lead sponsor: Chung Shan Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Chung Shan Medical University

This study investigated the effects of prolonged smartphone usage for over 90 minutes on ophthalmic and central retinal artery circulation before and after smartphone use and compared the effects with versus without intervention by high-frequency multi-band harmonic electromagnetic stimulation.

Age

20 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•20 to 65 years old

Exclusion Criteria

•hypertension
•diabetes
•heart disease
•eye-related diseases

Related studies

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

NCT04354545 · Glaucoma, Ocular Surface Disease

Clinical Application Research of Scleral Lenses in Ocular Surface Diseases

NCT06555367 · Ocular Surface Disease

Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device

NCT06427629 · Ocular Surface Disease

COMPLETEDPhase 3

TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)

NCT04526951 · Central Retinal Artery Occlusion

The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency

NCT07168265 · Androgen Deficiency, Ocular Surface Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 6, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment43

Start dateSep 2023

Last updatedMar 6, 2025

Condition

Ocular Surface Disease Central Retinal Artery Occlusion

Locations shown

National Central University

Hsinchu, Taiwan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions